Cargando…
Central CB(2) receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential
Autores principales: | Concannon, Ruth M., Dowd, Eilís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090836/ https://www.ncbi.nlm.nih.gov/pubmed/27857737 http://dx.doi.org/10.4103/1673-5374.191208 |
Ejemplares similares
-
Brain repair for Parkinson’s disease: is the answer in the matrix?
por: Moriarty, Niamh, et al.
Publicado: (2018) -
cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
por: Holden, Joseph M., et al.
Publicado: (2022) -
The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
por: Bow, Eric W., et al.
Publicado: (2016) -
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
por: Zhou, Juan, et al.
Publicado: (2016) -
Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
por: Terada, Kazuki, et al.
Publicado: (2019)